Advertisement
Screener

ALTIMMUNE, INC. (ALT) Operating Income

ALTIMMUNE, INC. Operating Income

ALTIMMUNE, INC. (ALT) reported Operating Income of -$26.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-12

  • ALTIMMUNE, INC. operating income (loss) for the quarter ending 2026-06-30 was -$26.23M.
  • ALTIMMUNE, INC. operating income (loss) for the quarter ending 2026-03-31 was -$24.24M.
  • ALTIMMUNE, INC. operating income (loss) for the quarter ending 2025-12-31 was -$28.89M.
  • ALTIMMUNE, INC. operating income (loss) for the quarter ending 2025-09-30 was -$20.86M.
  • ALTIMMUNE, INC. operating income (loss) for fiscal 2025 was -$94.49M.
  • ALTIMMUNE, INC. operating income (loss) for fiscal 2024 was -$103.17M.
  • ALTIMMUNE, INC. operating income (loss) for fiscal 2023 was -$95.93M.
  • ALTIMMUNE, INC. operating income (loss) for fiscal 2022 was -$87.74M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 6 month as first filedOperating Income (Loss) 9 monthOperating Income (Loss) 9 month as first filedOperating Income (Loss) 12 monthOperating Income (Loss) 12 month as first filed
2026-06-30-$26.23M
10-Q · filed 2026-08-12
-$50.47M
10-Q · filed 2026-08-12
-$79.37M
derived: sum of 3 quarters · filed 2026-08-12
-$100.22M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$24.24M
10-Q · filed 2026-05-13
-$53.14M
derived: sum of 2 quarters · filed 2026-05-13
-$74.00M
derived: sum of 3 quarters · filed 2026-05-13
-$96.92M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31-$28.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06
-$49.75M
derived: sum of 2 quarters · filed 2026-03-06
-$72.67M
derived: sum of 3 quarters · filed 2026-08-12
-$94.49M
10-K · filed 2026-03-06
2025-09-30-$20.86M
10-Q · filed 2025-11-06
-$43.78M
derived: sum of 2 quarters · filed 2026-08-12
-$65.60M
10-Q · filed 2025-11-06
-$90.46M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30-$22.92M
10-Q · filed 2026-08-12
-$44.74M
10-Q · filed 2026-08-12
-$69.60M
derived: sum of 3 quarters · filed 2026-08-12
-$94.37M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$21.82M
10-Q · filed 2026-05-13
-$46.68M
derived: sum of 2 quarters · filed 2026-05-13
-$71.45M
derived: sum of 3 quarters · filed 2026-05-13
-$98.19M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$24.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06
-$49.63M
derived: sum of 2 quarters · filed 2026-03-06
-$76.38M
derived: sum of 3 quarters · filed 2026-03-06
-$103.17M
10-K · filed 2026-03-06
2024-09-30-$24.77M
10-Q · filed 2025-11-06
-$51.51M
derived: sum of 2 quarters · filed 2025-11-06
-$78.31M
10-Q · filed 2025-11-06
-$111.93M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$26.75M
10-Q · filed 2025-08-12
-$53.54M
10-Q · filed 2025-08-12
-$87.16M
derived: sum of 3 quarters · filed 2025-08-12
-$109.70M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31-$26.79M
10-Q · filed 2025-05-13
-$60.42M
derived: sum of 2 quarters · filed 2025-05-13
-$82.96M
derived: sum of 3 quarters · filed 2025-05-13
-$100.96M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31-$33.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$56.16M
derived: sum of 2 quarters · filed 2025-02-27
-$74.17M
derived: sum of 3 quarters · filed 2025-02-27
-$95.93M
10-K · filed 2025-02-27
2023-09-30-$22.54M
10-Q · filed 2024-11-12
-$40.55M
derived: sum of 2 quarters · filed 2024-11-12
-$62.31M
10-Q · filed 2024-11-12
-$85.40M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$18.01M
10-Q · filed 2024-08-08
-$39.77M
10-Q · filed 2024-08-08
-$62.86M
derived: sum of 3 quarters · filed 2024-08-08
-$87.61M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$21.76M
10-Q · filed 2024-05-09
-$44.85M
derived: sum of 2 quarters · filed 2024-05-09
-$69.61M
derived: sum of 3 quarters · filed 2024-05-09
-$90.00M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$23.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27
-$47.85M
derived: sum of 2 quarters · filed 2024-03-27
-$68.24M
derived: sum of 3 quarters · filed 2024-03-27
-$87.74M
10-K · filed 2024-03-27
2022-09-30-$24.75M
10-Q · filed 2023-11-07
-$45.15M
derived: sum of 2 quarters · filed 2023-11-07
-$64.65M
10-Q · filed 2023-11-07
-$88.63M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30-$20.39M
10-Q · filed 2023-08-10
-$39.89M
10-Q · filed 2023-08-10
-$63.88M
derived: sum of 3 quarters · filed 2023-08-10
-$97.08M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$19.50M
10-Q · filed 2023-05-11
-$43.48M
derived: sum of 2 quarters · filed 2023-05-11
-$76.69M
derived: sum of 3 quarters · filed 2023-05-11
-$101.55M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$23.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$57.19M
derived: sum of 2 quarters · filed 2023-02-28
-$82.05M
derived: sum of 3 quarters · filed 2023-02-28
-$96.91M
10-K · filed 2023-02-28
-$96.91M
10-K · filed 2022-03-15
2021-09-30-$33.20M
10-Q · filed 2022-11-10
-$33.20M
10-Q · filed 2021-11-09
-$58.07M
derived: sum of 2 quarters · filed 2022-11-10
-$72.93M
10-Q · filed 2022-11-10
-$72.93M
10-Q · filed 2021-11-09
-$83.68M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$24.86M
10-Q · filed 2022-08-11
-$24.86M
10-Q · filed 2021-08-10
-$39.73M
10-Q · filed 2022-08-11
-$39.73M
10-Q · filed 2021-08-10
-$50.47M
derived: sum of 3 quarters · filed 2022-08-11
-$68.80M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$14.86M
10-Q · filed 2022-05-12
-$14.86M
10-Q · filed 2021-05-17
-$25.61M
derived: sum of 2 quarters · filed 2022-05-12
-$43.94M
derived: sum of 3 quarters · filed 2022-05-12
-$62.35M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$10.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
-$29.07M
derived: sum of 2 quarters · filed 2022-03-15
-$47.49M
derived: sum of 3 quarters · filed 2022-03-15
-$54.80M
10-K · filed 2022-03-15
2020-09-30-$18.32M
10-Q · filed 2021-11-09
-$36.74M
derived: sum of 2 quarters · filed 2021-11-09
-$44.05M
10-Q · filed 2021-11-09
-$48.36M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30-$18.42M
10-Q · filed 2021-08-10
-$25.72M
10-Q · filed 2021-08-10
-$30.04M
derived: sum of 3 quarters · filed 2021-08-10
-$41.31M
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31-$7.31M
10-Q · filed 2021-05-17
-$11.62M
derived: sum of 2 quarters · filed 2021-05-17
-$22.89M
derived: sum of 3 quarters · filed 2021-05-17
-$26.44M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$4.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$15.59M
derived: sum of 2 quarters · filed 2021-02-25
-$19.14M
derived: sum of 3 quarters · filed 2021-02-25
-$21.46M
10-K · filed 2021-02-25
2019-09-30-$11.27M
10-Q · filed 2020-11-09
-$14.82M
derived: sum of 2 quarters · filed 2020-11-09
-$17.15M
10-Q · filed 2020-11-09
-$44.50M
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30-$3.55M
10-Q · filed 2020-08-11
-$5.88M
10-Q · filed 2020-08-11
-$33.23M
derived: sum of 3 quarters · filed 2020-08-11
-$37.28M
derived: sum of 4 quarters · filed 2020-08-11
2019-03-31-$2.33M
10-Q · filed 2020-05-13
-$29.67M
derived: sum of 2 quarters · filed 2020-05-13
-$33.73M
derived: sum of 3 quarters · filed 2020-05-13
-$39.17M
derived: sum of 4 quarters · filed 2020-05-13
2018-12-31-$27.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27
-$31.40M
derived: sum of 2 quarters · filed 2020-03-27
-$36.84M
derived: sum of 3 quarters · filed 2020-03-27
-$42.83M
10-K · filed 2020-03-27
2018-09-30-$4.06M
10-Q · filed 2019-11-13
-$9.49M
derived: sum of 2 quarters · filed 2019-11-13
-$15.49M
10-Q · filed 2019-11-13
-$28.05M
derived: sum of 4 quarters · filed 2019-11-13
2018-06-30-$5.44M
10-Q · filed 2019-08-13
-$11.43M
10-Q · filed 2019-08-13
-$23.99M
derived: sum of 3 quarters · filed 2019-08-13
-$54.95M
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31-$5.99M
10-Q · filed 2019-05-14
-$18.56M
derived: sum of 2 quarters · filed 2019-05-14
-$49.51M
derived: sum of 3 quarters · filed 2019-05-14
-$53.52M
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31-$12.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
-$43.52M
derived: sum of 2 quarters · filed 2019-04-01
-$47.53M
derived: sum of 3 quarters · filed 2019-04-01
-$52.05M
10-K · filed 2019-04-01
2017-09-30-$30.95M
10-Q · filed 2018-11-13
-$34.96M
derived: sum of 2 quarters · filed 2018-11-13
-$39.48M
10-Q · filed 2018-11-13
-$44.99M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$4.01M
10-Q · filed 2018-08-14
-$8.53M
10-Q · filed 2018-08-14
-$14.04M
derived: sum of 3 quarters · filed 2018-08-14
-$18.83M
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31-$4.52M
10-Q · filed 2018-05-15
-$3.18M
10-Q · filed 2017-05-03
-$10.03M
derived: sum of 2 quarters · filed 2018-05-15
-$14.82M
derived: sum of 3 quarters · filed 2018-05-15
-$16.42M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$5.51M
10-K · filed 2017-03-14
-$10.30M
derived: sum of 2 quarters · filed 2017-11-09
-$11.90M
derived: sum of 3 quarters · filed 2017-11-09
-$11.09M
10-K · filed 2018-04-02
-$11.26M
10-K · filed 2017-03-14
2016-09-30-$4.79M
10-Q · filed 2017-11-09
-$3.99M
10-Q · filed 2016-11-04
-$6.39M
derived: sum of 2 quarters · filed 2017-11-09
-$7.99M
10-Q · filed 2017-11-09
-$5.75M
10-Q · filed 2016-11-04
-$8.59M
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30-$1.60M
10-Q · filed 2017-08-14
-$507.74K
10-Q · filed 2016-08-04
-$3.21M
10-Q · filed 2017-08-14
-$1.76M
10-Q · filed 2016-08-04
-$3.80M
derived: sum of 3 quarters · filed 2017-08-14
-$5.46M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31-$1.25M
10-Q · filed 2017-05-03
-$2.19M
derived: sum of 2 quarters · filed 2017-05-03
-$3.85M
derived: sum of 3 quarters · filed 2017-05-03
-$5.82M
derived: sum of 4 quarters · filed 2017-05-03
2015-12-31-$940.47K
10-K · filed 2017-03-14
-$2.60M
derived: sum of 2 quarters · filed 2017-03-14
-$4.56M
derived: sum of 3 quarters · filed 2017-03-14
-$3.40M
10-K · filed 2017-03-14
2015-09-30-$1.66M
10-K · filed 2017-03-14
-$3.62M
derived: sum of 2 quarters · filed 2017-03-14
-$2.46M
10-Q · filed 2016-11-04
-$5.09M
derived: sum of 4 quarters · filed 2017-03-14
2015-06-30-$1.96M
10-K · filed 2017-03-14
-$803.78K
10-Q · filed 2016-08-04
-$3.43M
derived: sum of 3 quarters · filed 2017-03-14
-$7.42M
derived: sum of 4 quarters · filed 2017-03-14
2015-03-31$1.16M
10-K · filed 2017-03-14
-$1.46M
derived: sum of 2 quarters · filed 2017-03-14
-$5.46M
derived: sum of 3 quarters · filed 2017-03-14
-$6.63M
derived: sum of 4 quarters · filed 2017-03-14
2014-12-31-$2.62M
10-K · filed 2016-03-11
-$6.62M
derived: sum of 2 quarters · filed 2016-03-11
-$7.79M
derived: sum of 3 quarters · filed 2016-03-11
-$10.19M
10-K · filed 2017-03-14
2014-09-30-$4.00M
10-K · filed 2016-03-11
-$5.17M
derived: sum of 2 quarters · filed 2016-03-11
-$7.57M
10-Q · filed 2015-11-06
-$12.64M
derived: sum of 4 quarters · filed 2016-03-11
2014-06-30-$1.17M
10-K · filed 2016-03-11
-$3.57M
10-Q · filed 2015-08-05
-$8.64M
derived: sum of 3 quarters · filed 2016-03-11
-$11.84M
derived: sum of 4 quarters · filed 2016-03-11
2014-03-31-$2.40M
10-K · filed 2016-03-11
-$7.47M
derived: sum of 2 quarters · filed 2016-03-11
-$10.67M
derived: sum of 3 quarters · filed 2016-03-11
-$12.15M
derived: sum of 4 quarters · filed 2016-03-11
2013-12-31-$5.07M
10-K · filed 2015-03-11
-$8.27M
derived: sum of 2 quarters · filed 2015-03-11
-$9.75M
derived: sum of 3 quarters · filed 2015-03-11
-$10.84M
10-K · filed 2016-03-11
2013-09-30-$3.20M
10-K · filed 2015-03-11
-$4.68M
derived: sum of 2 quarters · filed 2015-03-11
-$5.77M
10-Q · filed 2014-11-06
-$7.20M
derived: sum of 4 quarters · filed 2015-03-11
2013-06-30-$1.48M
10-K · filed 2015-03-11
-$2.57M
10-Q · filed 2014-08-05
-$4.00M
derived: sum of 3 quarters · filed 2015-03-11
-$5.79M
derived: sum of 4 quarters · filed 2015-03-11
2013-03-31-$1.09M
10-K · filed 2015-03-11
-$2.52M
derived: sum of 2 quarters · filed 2015-03-11
-$4.31M
derived: sum of 3 quarters · filed 2015-03-11
-$5.77M
derived: sum of 4 quarters · filed 2015-03-11
2012-12-31-$1.43M
10-K · filed 2014-03-11
-$3.22M
derived: sum of 2 quarters · filed 2014-03-11
-$4.68M
derived: sum of 3 quarters · filed 2014-03-11
-$6.27M
10-K · filed 2015-03-11
2012-09-30-$1.79M
10-K · filed 2014-03-11
-$3.25M
derived: sum of 2 quarters · filed 2014-03-11
-$4.84M
10-Q · filed 2013-11-07
-$5.92M
derived: sum of 4 quarters · filed 2014-03-11
2012-06-30-$1.46M
10-K · filed 2014-03-11
-$3.05M
10-Q · filed 2013-08-08
-$4.13M
derived: sum of 3 quarters · filed 2014-03-11
-$7.15M
derived: sum of 4 quarters · filed 2014-03-11
2012-03-31-$1.59M
10-K · filed 2014-03-11
-$2.67M
derived: sum of 2 quarters · filed 2014-03-11
-$5.70M
derived: sum of 3 quarters · filed 2014-03-11
-$8.78M
derived: sum of 4 quarters · filed 2014-03-11
2011-12-31-$1.08M
10-K · filed 2013-03-14
-$4.10M
derived: sum of 2 quarters · filed 2013-03-14
-$7.19M
derived: sum of 3 quarters · filed 2013-03-14
-$11.73M
10-K · filed 2014-03-11
2011-09-30-$3.02M
10-K · filed 2013-03-14
-$6.10M
derived: sum of 2 quarters · filed 2013-03-14
-$10.64M
10-Q · filed 2012-11-06
-$17.89M
derived: sum of 4 quarters · filed 2013-03-14
2011-06-30-$3.08M
10-K · filed 2013-03-14
-$7.62M
10-Q · filed 2012-08-07
-$14.87M
derived: sum of 3 quarters · filed 2013-03-14
-$18.23M
derived: sum of 4 quarters · filed 2013-03-14
2011-03-31-$4.54M
10-K · filed 2013-03-14
-$11.79M
derived: sum of 2 quarters · filed 2013-03-14
-$15.15M
derived: sum of 3 quarters · filed 2013-03-14
-$20.69M
derived: sum of 4 quarters · filed 2013-03-14
2010-12-31-$7.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14
-$10.61M
derived: sum of 2 quarters · filed 2013-03-14
-$16.15M
derived: sum of 3 quarters · filed 2013-03-14
-$23.55M
10-K · filed 2013-03-14
2010-09-30-$3.36M
10-Q · filed 2011-11-09
-$8.90M
derived: sum of 2 quarters · filed 2011-11-09
-$16.31M
10-Q · filed 2011-11-09
2010-06-30-$5.54M
10-Q · filed 2011-08-11
-$12.94M
10-Q · filed 2011-08-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Monopar Therapeutics (MNPR)United States$0.598B-34.82
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Neurogene Inc. (NGNE)$0.625B-4.46
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Indaptus Therapeutics, Inc. (INDP)United States$0.537B